Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Heirman, Carlo" or (type any "bookEditor issueEditor" and editor="Heirman, Carlo")

Add to list
- Journal Article
- A1
- open access
Immunogenicity of targeted lentivectors

Cleo Goyvaerts, Kurt De Groeve, Sandra Van Lint (UGent) , Carlo Heirman, Jo A Vanginderachter, Patrick De Baetselier, Geert Raes, Kris Thielemans and Karine Breckpot

(2014) ONCOTARGET. 5(3). p.704-715
Add to list
In vitro generation of mature, naive antigen-specific CD8⁺ T cells with a single T-cell receptor by agonist selection

SYLVIA SNAUWAERT (UGent) , Greet Verstichel (UGent) , Sarah Bonte (UGent) , Glenn Goetgeluk (UGent) , Stijn Vanhee (UGent) , Yasmine Van Caeneghem (UGent) , Katrien De Mulder (UGent) , Carlo Heirman, Hans Stauss, Miriam HM Heemskerk, et al.

(2014) LEUKEMIA. 28(4). p.830-841
Add to list
- Miscellaneous
mRNA: from a chemical blueprint for protein production to an off-the-shelf therapeutic

Sandra Van Lint (UGent) , Carlo Heirman, Kris Thielemans and Karine Breckpot

(2013) HUMAN VACCINES & IMMUNOTHERAPEUTICS. 9(2). p.265-274
Add to list
- Journal Article
- A1
- open access
Design of an optimized Wilms' tumor 1 (WT1) mRNA construct for enhanced WT1 expression and improved immunogenicity in vitro and in vivo

Daphné Benteyn, Sébastien Anguille, Sandra Van Lint (UGent) , Carlo Heirman, An MT Van Nuffel, Jurgen Corthals, Sebastian Ochsenreither, Wim Waelput, Katrien Van Beneden, Karine Breckpot, et al.

(2013) MOLECULAR THERAPY-NUCLEIC ACIDS. 2.
Add to list
Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy

Perpetua U Emeagi, Sandra Van Lint (UGent) , Cleo Goyvaerts, Sarah Maenhout, Anje Cauwels (UGent) , Lain A McNeish, Tomas Bos, Carlo Heirman, Kris Thielennans, Joeri L Aerts, et al.

(2012) CANCER RESEARCH. 72(6). p.1342-1352
Add to list
- Journal Article
- A1
- open access
Development of the nanobody display technology to target lentiviral vectors to antigen-presenting cells

Cleo Goyvaerts, Kurt De Groeve, Jozef Dingemans, Sandra Van Lint (UGent) , Lander Robays, Carlo Heirman, J Reiser, Kris Thielemans, Patrick De Baetselier, Geert Raes, et al.

(2012) GENE THERAPY. 19(12). p.1133-1140
Add to list
Preclinical evaluation of TriMix and antigen mRNA-based anti-tumor therapy

Sandra Van Lint (UGent) , Cleo Goyvaerts, Sarah Maenhout, Lode Goethals, Aurélie Disy, Daphné Benteyn, Joeri Pen, Aude Bonehill, Carlo Heirman, Karine Breckpot, et al.

(2012) CANCER RESEARCH. 72(7). p.1661-1671
Add to list
Large double copy vectors are functional but show a size-dependent decline in transduction efficiency

Tomas J Bos, Sandra Van Lint (UGent) , Carlo Heirman and Karin Vanderkerken

(2010) JOURNAL OF BIOTECHNOLOGY. 150(1). p.37-40
Add to list
Attenuated Expression of A20 Markedly Increases the Efficacy of Double-Stranded RNA-Activated Dendritic Cells As an Anti-Cancer Vaccine

Karine Breckpot, Cindy Aerts-Toegaert, Carlo Heirman, Uschi Peeters, Rudi Beyaert (UGent) , Joeri L Aerts and Kris Thielemans

(2009) JOURNAL OF IMMUNOLOGY. 182(2). p.860-870
Add to list
Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors

Karine Breckpot, Perpetua Emeagi, Melissa Dullaers (UGent) , Annelies Michiels, Carlo Heirman and Kris Thielemans

(2007) HUMAN GENE THERAPY. 18(6). p.536-546

← Previous

Academic Bibliography

Immunogenicity of targeted lentivectors

In vitro generation of mature, naive antigen-specific CD8⁺ T cells with a single T-cell receptor by agonist selection

mRNA: from a chemical blueprint for protein production to an off-the-shelf therapeutic

Design of an optimized Wilms' tumor 1 (WT1) mRNA construct for enhanced WT1 expression and improved immunogenicity in vitro and in vivo

Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy

Development of the nanobody display technology to target lentiviral vectors to antigen-presenting cells

Preclinical evaluation of TriMix and antigen mRNA-based anti-tumor therapy

Large double copy vectors are functional but show a size-dependent decline in transduction efficiency

Attenuated Expression of A20 Markedly Increases the Efficacy of Double-Stranded RNA-Activated Dendritic Cells As an Anti-Cancer Vaccine

Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors

Contents

Support

Contact